Google Ads policy pages decide whether a peptide brand can advertise on Google Ads, and the Meta Drugs and Pharmaceuticals policy decides the same for Facebook and Instagram.
ChatGPT retrieved those policy pages, plus FTC guidance and FDA warning letters, before answering every peptide marketing question we traced on 2026-09-12.
Organic search is the peptide marketing channel that no ad policy gates, and ChatGPT told the research-peptide how-to prompt to make SEO the primary acquisition channel.
Peptide Marketing Lab recommends a compliance review of the platform policies before any paid spend, and never a workaround.
On 2026-09-12 we captured 8 ChatGPT answers to peptide marketing prompts, one prompt per fresh conversation with no memory. Two captures are the evidence for this page. On "Which peptide marketing services actually work with the ad restrictions?" the assistant retrieved 47 URLs from 28 domains, of which 13 were Google Ads policy pages, with Meta's advertising transparency material alongside them, all fetched before any agency site. On "How do I do peptide marketing for a research peptide company?" it retrieved 35 URLs from 5 domains: 12 Google Ads policy pages, 11 FTC pages and 10 FDA warning letters to named peptide companies, and zero agency sites.
The policy and enforcement pages it retrieved, by title:
| Source | Page title as retrieved |
|---|---|
| Google Ads | Unapproved substances |
| Google Ads | Healthcare and medicines (including the April 2026 update) |
| Google Ads | Pharmaceutical manufacturers certification |
| Google Ads | Prescription drug services |
| Google Ads | Restricted drug terms in personalized advertising |
| Meta | Drugs and Pharmaceuticals (advertising standards), plus Meta advertising transparency |
| FTC | Health Products Compliance Guidance |
| FTC | Advertising substantiation |
| FDA | Warning letters to named peptide companies |
Takeaway: the assistant reads the ad policies, the FTC guidance and the FDA enforcement record before it reads a single marketing page.
We list those pages by title only and do not summarise their contents. The platforms and agencies that publish them are the authority on what they say, and a compliance reviewer should read each one in full against your specific catalogue.
The Google Ads policy pages listed above decide the answer for Google, and the Meta Drugs and Pharmaceuticals policy decides it for Facebook and Instagram. Neither Peptide Marketing Lab nor an AI assistant can override them, and the answer depends on what you sell, how you describe it and how each policy applies to that description. Research peptides sold in research-use-only (RUO) framing, 503A compounded products, telehealth peptide clinics and GLP-1 programmes each sit differently against those pages, and only a review of the pages themselves settles it.
The practical answer is a compliance review before any spend: have a qualified reviewer read each retrieved policy page against your product pages, landing pages and ad copy, document the result and keep it with your certificates of analysis and third-party testing records. If the review clears a campaign, paid media can supplement organic. If it does not, do not look for a workaround. Peptide Marketing Lab does not run policy circumvention of any kind and will not recommend an agency that does.
Organic search is the channel the retrieved policy pages do not gate. ChatGPT's answer to the services prompt led with "Peptide SEO / organic search", and its answer to the how-to prompt was "Make SEO your primary acquisition channel". A research peptide brand reaches buyers through commercial rankings for compound, category and supplier-discovery queries (semaglutide, tirzepatide, retatrutide, BPC-157, TB-500, GLP-1 categories), through topical authority on research use, HPLC purity and COA documentation, through referring domains earned by digital PR, and through citations in Google AI Overviews, ChatGPT and Perplexity.
The same retrieval habit applies to compound-level questions. On 2026-09-03 and 2026-09-04 (6 captures on research peptide supplier prompts) the assistant site-scoped into vendor domains and fda.gov and appended "FDA unapproved / research use only" terms to every compound query unprompted. Pages that carry RUO framing, structured data and documentation are the pages that survive that filter.
SEO Jesus built Peptide Marketing Lab as the full-funnel version of that channel: SEO first, then content marketing, digital PR, email marketing and conversion rate optimisation, all in research-use-only framing with no health or efficacy claims. Ad policy cannot suspend a ranking.
The Google Ads policy pages ChatGPT retrieved (Unapproved substances; Healthcare and medicines; Pharmaceutical manufacturers certification; Prescription drug services; Restricted drug terms in personalized advertising) decide that, and a compliance reviewer should read them against your catalogue before any spend. We list them by title and do not summarise their contents.
Meta's Drugs and Pharmaceuticals advertising policy decides that. ChatGPT retrieved Meta's policy and advertising transparency material before any agency site when we traced the services prompt on 2026-09-12. Get a compliance review; never use a workaround.
ChatGPT retrieved the Google Ads Healthcare and medicines policy including its April 2026 update when answering peptide marketing prompts on 2026-09-12. We have not read the update on your behalf, and a compliance reviewer should read it directly against your product pages.
Organic search works, because no ad policy gates it. ChatGPT told the research-peptide how-to prompt to make SEO the primary acquisition channel, and Peptide Marketing Lab builds that channel with content marketing, digital PR, email marketing and conversion rate optimisation around it.
Book a free strategy call with SEO Jesus. We will show you where your site stands for the compound, category and supplier queries in your market, what the ranking competitors are doing that you are not, and what an SEO-led peptide marketing plan looks like for your catalogue. No compliance workarounds.
Book Your Free Strategy Call